These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2569813)

  • 1. Development of local morphological changes after intradermal inoculation of Q-fever chemovaccine.
    Resl M; Sidorenko SV; Zhuljabin EI
    Acta Virol; 1989 Mar; 33(2):167-71. PubMed ID: 2569813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J; Votruba D; Propper P; Schramek S
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Q fever (Coxiella burnetii) investigations in dairy cattle: persistence of antibodies after vaccination.
    Behymer DE; Biberstein EL; Riemann HP; Franti CE; Sawyer M
    Am J Vet Res; 1975 Jun; 36(6):781-84. PubMed ID: 1147331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Q fever vaccination of sheep: challenge of immunity in ewes.
    Brooks DL; Ermel RW; Franti CE; Ruppanner R; Behymer DE; Williams JC; Stephenson EH
    Am J Vet Res; 1986 Jun; 47(6):1235-8. PubMed ID: 3729123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia.
    Kazár J; Brezina R; Palanová A; Tvrdá B; Schramek S
    Bull World Health Organ; 1982; 60(3):389-94. PubMed ID: 6982774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of Q fever phase I corpuscular vaccine to influence the persistence and reactivation of Coxiella burnetii infection in mouse and guinea pig tissues.
    Kazár J; Kovácová E
    Acta Virol; 1983 Sep; 27(5):418-28. PubMed ID: 6139946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Q fever cellular and chloroform-methanol residue vaccines as skin test antigens in the sensitized guinea pig.
    Elliott JJ; Ruble DL; Zaucha GM; Jaax GP; Waag DM
    Acta Virol; 1998 Jun; 42(3):147-55. PubMed ID: 9842444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations.
    Kazár J; Schramek S; Lisák V; Brezina R
    Acta Virol; 1987 Mar; 31(2):158-67. PubMed ID: 2886025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine prophylaxis of abattoir-associated Q fever: eight years' experience in Australian abattoirs.
    Marmion BP; Ormsbee RA; Kyrkou M; Wright J; Worswick DA; Izzo AA; Esterman A; Feery B; Shapiro RA
    Epidemiol Infect; 1990 Apr; 104(2):275-87. PubMed ID: 2323360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Undesirable reactions of domestic pigeons to vaccination against paramyxovirus type 1.
    Bönner BM; Koehler K; Reichel U; Beck I; Jaeger S; Barbeito J; Redmann T; Kaleta EF
    Dtsch Tierarztl Wochenschr; 2003 Oct; 110(10):403-6. PubMed ID: 14650734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reactogenic activity of C. burneti vaccines. I. Allergenic and toxic properties of phases I and II C. burneti corpuscular vaccines].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):665-78. PubMed ID: 5742338
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunity in Q fever.
    Kazár J
    Acta Virol; 1988 Jul; 32(4):358-68. PubMed ID: 2903642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local pathogenic effects of Q fever vaccines. Some attempts to diminish the local pathogenic effect of phase I Coxiella burneti corpuscular vaccine.
    Crăcea E; Zarnea G; Dumitrescu S; Botez D; Sabin S
    Arch Roum Pathol Exp Microbiol; 1972 Sep; 31(3):367-72. PubMed ID: 4665073
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
    Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immune response to Coxiella burnetii antigens in Q fever convalescents and vaccinees.
    Gajdosová E; Brezina R
    Acta Virol; 1989 Sep; 33(5):474-81. PubMed ID: 2576587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines.
    Williams JC; Peacock MG; Race RE
    Rev Elev Med Vet Pays Trop; 1993; 46(1-2):87-94. PubMed ID: 8134661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of the microagglutination test for detection of post-infection and post-vaccination Q fever antibodies in human sera.
    Kazár J; Brezina R; Schramek S; Palanová A; Tvrdá B
    Acta Virol; 1981 Jul; 25(4):235-40. PubMed ID: 6116418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical composition of phase I Coxiella burnetii soluble antigen prepared by trichloroacetic acid extraction.
    Lukácová M; Brezina R; Schramek S; Pastorek J
    Acta Virol; 1989 Jan; 33(1):75-80. PubMed ID: 2565677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reactogenic activity of C. burneti vaccines. II. Attempts to separate the protecting potency from the toxic and allergenic effects of phase I C. burneti vaccine].
    Crăcea E; Zarnea G; Dumitresco S; Novac S
    Arch Roum Pathol Exp Microbiol; 1968 Sep; 27(3):679-90. PubMed ID: 5742339
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.